The ethics of genome editing in the clinic: A dose of realism for healthcare leaders

Tania Bubela, Yael Mansour, Dianne Nicol

Research output: Contribution to journalArticlepeer-review

Abstract

Genome editing technologies promise therapeutic advances for genetic diseases. We discuss the ethical and societal issues raised by these technologies, including their use in preclinical research, their potential to address mutations in somatic cells, and their potential to make germ line alterations that may be passed to subsequent generations. We call for a proportionate response from health leaders based on a realistic assessment of benefits, risks, and timelines for clinical translation.

Original languageEnglish
Pages (from-to)159-163
Number of pages5
JournalHealthcare Management Forum
Volume30
Issue number3
DOIs
Publication statusPublished - 1 May 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'The ethics of genome editing in the clinic: A dose of realism for healthcare leaders'. Together they form a unique fingerprint.

Cite this